770 related articles for article (PubMed ID: 29176714)
1. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment.
Gu Y; Wang X; Li J; Zhang Y; Zhong H; Liu R; Zhang D; Feng Q; Xie X; Hong J; Ren H; Liu W; Ma J; Su Q; Zhang H; Yang J; Wang X; Zhao X; Gu W; Bi Y; Peng Y; Xu X; Xia H; Li F; Xu X; Yang H; Xu G; Madsen L; Kristiansen K; Ning G; Wang W
Nat Commun; 2017 Nov; 8(1):1785. PubMed ID: 29176714
[TBL] [Abstract][Full Text] [Related]
2. Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus.
Su B; Liu H; Li J; Sunli Y; Liu B; Liu D; Zhang P; Meng X
J Diabetes; 2015 Sep; 7(5):729-39. PubMed ID: 25327485
[TBL] [Abstract][Full Text] [Related]
3. Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes.
Takewaki F; Nakajima H; Takewaki D; Hashimoto Y; Majima S; Okada H; Senmaru T; Ushigome E; Hamaguchi M; Yamazaki M; Tanaka Y; Nakajima S; Ohno H; Fukui M
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205413
[TBL] [Abstract][Full Text] [Related]
4. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats.
Zhang M; Feng R; Yang M; Qian C; Wang Z; Liu W; Ma J
BMJ Open Diabetes Res Care; 2019; 7(1):e000717. PubMed ID: 31641523
[TBL] [Abstract][Full Text] [Related]
5. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies.
Cao TTB; Wu KC; Hsu JL; Chang CS; Chou C; Lin CY; Liao YM; Lin PC; Yang LY; Lin HW
Front Endocrinol (Lausanne); 2020; 11():573891. PubMed ID: 33071980
[No Abstract] [Full Text] [Related]
6. Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial.
Zhang X; Ren H; Zhao C; Shi Z; Qiu L; Yang F; Zhou X; Han X; Wu K; Zhong H; Li Y; Li J; Ji L
Diabetologia; 2022 Oct; 65(10):1613-1626. PubMed ID: 35930018
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
[TBL] [Abstract][Full Text] [Related]
8. The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome.
Baxter NT; Lesniak NA; Sinani H; Schloss PD; Koropatkin NM
mSphere; 2019 Feb; 4(1):. PubMed ID: 30728281
[TBL] [Abstract][Full Text] [Related]
9. Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: A 6-month randomized controlled-feeding trial.
Wan Y; Yuan J; Li J; Li H; Zhang J; Tang J; Ni Y; Huang T; Wang F; Zhao F; Li D
Clin Nutr; 2020 Feb; 39(2):395-404. PubMed ID: 30876827
[TBL] [Abstract][Full Text] [Related]
10. Fasting and refeeding triggers specific changes in bile acid profiles and gut microbiota.
Zhang Y; Qi H; Wang L; Hu C; Gao A; Wu Q; Wang Q; Lin H; Chen B; Wang X; Wang S; Lin H; Wang W; Bi Y; Wang J; Lu J; Liu R
J Diabetes; 2023 Feb; 15(2):165-180. PubMed ID: 36682739
[TBL] [Abstract][Full Text] [Related]
11. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
12. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
[TBL] [Abstract][Full Text] [Related]
13. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
14. The delayed effects of antibiotics in type 2 diabetes, friend or foe?
Fu L; Qiu Y; Shen L; Cui C; Wang S; Wang S; Xie Y; Zhao X; Gao X; Ning G; Nie A; Gu Y
J Endocrinol; 2018 Aug; 238(2):137-149. PubMed ID: 29929986
[TBL] [Abstract][Full Text] [Related]
15. The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus.
Lv Y; Zhao X; Guo W; Gao Y; Yang S; Li Z; Wang G
J Diabetes Res; 2018; 2018():1890978. PubMed ID: 29854817
[TBL] [Abstract][Full Text] [Related]
16. Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.
Behr C; Slopianka M; Haake V; Strauss V; Sperber S; Kamp H; Walk T; Beekmann K; Rietjens IMCM; van Ravenzwaay B
Toxicol Appl Pharmacol; 2019 Jan; 363():79-87. PubMed ID: 30502395
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
[TBL] [Abstract][Full Text] [Related]
18. The association of type II diabetes with gut microbiota composition.
Navab-Moghadam F; Sedighi M; Khamseh ME; Alaei-Shahmiri F; Talebi M; Razavi S; Amirmozafari N
Microb Pathog; 2017 Sep; 110():630-636. PubMed ID: 28739439
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method.
Petakh P; Kobyliak N; Kamyshnyi A
Front Cell Infect Microbiol; 2023; 13():1142578. PubMed ID: 36844398
[TBL] [Abstract][Full Text] [Related]
20. Dose-response effect of berberine on bile acid profile and gut microbiota in mice.
Guo Y; Zhang Y; Huang W; Selwyn FP; Klaassen CD
BMC Complement Altern Med; 2016 Oct; 16(1):394. PubMed ID: 27756364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
